INTERNATIONAL LIVER CANCER ASSOCIATION
International Liver Cancer Association 14th Annual ConferenceSeptember 11-13, 2020 Virtual Conference
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| P-001 | Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress | Robin Kate Kelley |  Received |
 |
|||
| P-002 | Leap-012: A Randomized, Double-Blind, Phase 3 Study Of Pembrolizumab Plus Lenvatinib In Combination With Transarterial Chemoembolization (Tace) In Patients With Intermediate-Stage Hepatocellular Carcinoma (Hcc) Not Amenable To Curative Treatment | Richard Finn | Received |
|
|||
| P-003 | Ramucirumab For Patients With Advanced Hepatocellular Carcinoma And Elevated Alpha Fetoprotein Following A Non-Sorafenib Based Systemic Therapy: Interim Results From An Expansion Cohort Of The Phase 3 Reach-2 Study | David Mcilwain | Received |
|
|||
| P-004 | Sorafenib (Sor) Combined With Nivolumab (Nivo) In Advanced Hepatocellular Carcinoma (Hcc): Safety And Efficacy In A Dose Escalation Cohort | Bridget Keenan | Received |
|
|||
| P-005 | A Randomized, Placebo-Controlled Study Of Transarterial Chemoembolization Combined With Concurrent Durvalumab Followed By Durvalumab Or Durvalumab Plus Bevacizumab Therapy In Patients With Locoregional Hepatocellular Carcinoma (HCC): EMERALD-1 | Humna Rizki | Received |
|
|||
| P-006 | Durvalumab With Or Without Bevacizumab As Adjuvant Therapy For HCC Patients At Risk Of Recurrence After Curative Therapy: EMERALD-2 | Humna Rizki | Received |
|
|||
| P-008 | Phase 3 Keynote-937: Adjuvant Pembrolizumab Versus Placebo In Patients With Hepatocellular Carcinoma And Complete Radiologic Response After Surgical Resection Or Local Ablation | Arndt Vogel | Received |
|
|||
| P-009 | Hcc Recurrence Post Daa And Its Relation To Treatment Time Of Chronic Hcv Infection | Mohamed Fathey Elgazzar | Received |
|
|||
| P-013 | Quantification Of Intratumoral Collagen And Elastin Fibers Within Hepatocellular Carcinoma Tissues Finds Correlations With Clinico-Patho-Radiological Features | Junki Maehara | Received |
|
|||
| P-015 | Correlates And Longitudinal Changes In Ultrasound Visualization For Hcc Surveillance In Patients With Cirrhosis | Amit Singal | Received |
|
|||
| P-016 | Simple Indicators Of Energy Malnutrition In Patients With Chronic Liver Diseases | Hitomi Komiyama | Received |
|
|||
| P-018 | Elecsys PIVKA-II And Elecsys AFP Assays Demonstrate Good Clinical Performance For Hepatocellular Carcinoma (HCC) Diagnosis Across Different Disease Stages And Aetiologies | Enrico De Toni | Received |
|
|||
| P-019 | Analytical Performance And Method Comparison Of The Elecsys PIVKA-II Immunoassay As An Aid In Diagnosis Of Hepatocellular Carcinoma (HCC) | Enrico De Toni | Received |
|
|||
| P-021 | Immunoscore Classification From Hepatocellular Carcinoma Histopathology Images Using Deep Learning: A Preliminary Study | Qiaofeng Chen | Received |
|
|||
| P-022 | Serum Level Of Sulf2 Is Associated With The Severity Of The Liver Disease And Possess A Prognostic Value In Patients With Alcoholic Cirrhosis | Erwan Guyot | Received |
|
|||
| P-023 | Liver Visualization For Hepatocellular Carcinoma Surveillance: Performance Boundaries In A Large Multi-Site Practice | David Fetzer | Received |
|
|||
| P-024 | Li-Rads Diagnostic Performance Of Hepatocellular Carcinoma In Population With Previous Hepatitis B Virus Infection | Zonglin Xie | Received |
|
|||
| P-025 | Usefulness Of Circulating Tumor Cells In The Management Of Patients With Hepatocellular Carcinoma | Elena Vargas-Accarino | Received |
|
|||
| P-027 | A Pre-TACE radiomics model to predict HCC progression and recurrence in liver transplantation: a pilot study on a novel biomarker | Tommy Ivanics | Received |
|
|||
| P-028 | Purification And Digital Scoring Of Extracellular Vesicles For Detection Of Early-Stage Hepatocellular Carcinoma | Vatche Agopian | Received |
|
|||
| P-029 | Clinical Strategy Of Diagnosing Patients With Hepatocellular Carcinoma Based On Latent Transforming Growth Factor-Beta Binding Protein 1 | Mohamed Abdel-Samiee | Received |
|
|||
| P-030 | Role Of Contrast-Enhanced Ultrasound As A Secondary Diagnostic Modality In Non-Invasive Diagnostic Algorithms For Hepatocellular Carcinoma | Hyo-Jin Kang | Received |
|
|||
| P-032 | The SPRING Protocol Is the Key to Improve MVI Detection Rate | Lijuan Liu | Received |
|
|||
| P-033 | Patient Preferences For Hepatocellular Carcinoma Surveillance: A Multicenter Conjoint Analysis | Neehar Parikh | Received |
|
|||
| P-034 | Hepatocellular Carcinoma Tumor Volume Doubling Time: A Systemic Review And Meta-Analysis | Piyush Nathani | Received |
|
|||
| P-035 | Prediction of post-hepatectomy liver failure in patients with hepatocellular carcinoma based on radiomics using Gd-EOB-DTPA-enhanced MRI: the liver failure (LF) model | Yuyan Chen | Received |
|
|||
| P-037 | Usefulness Of Serum Metabolic Profiles For The Differential Diagnosis Of Distal Cholangiocarcinoma And Pancreatic Ductal Adenocarcinoma | Rocio IR Macias | Received |
|
|||
| P-038 | MALDI- Imaging Mass Spectrometry Of N-Glycan Profiles Of Molecular Subclasses Of Human Hepatocellular Carcinoma | Andrew DelaCourt | Received |
|
|||
| P-039 | Performance Of Imaging Criteria For The Diagnosis Of Hepatocellular Carcinoma In Non-Cirrhotic Patients With Hbv | Carlos Moctezuma-Velazquez | Received |
|
|||
| P-040 | A Fucosylated Kininogen-Based Biomarker Panel Is Highly Accurate For Early Detection Hepatocellular Carcinoma In Patients With Cirrhosis: A Phase Iii Biomarker Evaluation | Anand Mehta | Received |
|
|||
| P-041 | Clinical Experiences And Resources For Treating Hepatocellular Carcinoma In Africa | Vishal Shah | Received |
|
|||
| P-042 | Temporary Trends Of Liver Cancer Incidence Rates In China From 2014 To 2050 | Maomao Cao | Received |
|
|||
| P-045 | Ges Score: A Simple Score For Hcc Risk Stratification In Chc Patients With Cirrhosis Who Achieved Svr Following Daa Therapy | Gamal shiha | Received |
|
|||
| P-046 | Utilization Of Hepatocellular Carcinoma Surveillance In Patients With Cirrhosis: A Systematic Review And Meta-Analysis | Amit Singal | Received |
|
|||
| P-047 | Benefits And Harms Of Hepatocellular Carcinoma Surveillance In A Prospective Cohort Of Patients With Cirrhosis | Amit Singal | Received |
|
|||
| P-048 | Prognostic Significance Of Body Composition In Elderly Patients With Hepatocellular Carcinoma Undergoing Trans-Arterial Chemoembolization. | Jihye Lim | Received |
|
|||
| P-049 | Macrotrabecular Growth Pattern Is Associated With Poor Prognosis In Patients With Hepatocellular Carcinoma | Suhair Al Salihi | Received |
|
|||
| P-053 | Systematic Review And Meta-Analysis Of Validated Prognostic Models For Resected Hepatocellular Carcinoma Patients | Berend Beumer | Received |
|
|||
| P-054 | External Validation And Calibration Of The Erasl Risk ScoresResults Of A Dutch And Japanese Cohort Study | Berend Beumer | Received |
|
|||
| P-056 | Abnormal And Euthyroid Ranges Of Thyroid Hormones In Serum And Liver Cancer Mortality: A Cohort Study | Won Sohn | Received |
|
|||
| P-059 | Blood cell salvage and auto-transfusion does not worsen oncologic outcomes following liver transplantation with incidental HCC: a propensity score matched analysis | Tommy Ivanics | Received |
|
|||
| P-060 | Liver transplant, liver resection or ablation as first-line treatment for solitary HCC 3 cm or less: An intention-to-treat analysis | Tommy Ivanics | Received |
|
|||
| P-061 | Sex Disparities In Presentation And Prognosis Of Patients With Hepatocellular Carcinoma | Nicole Rich | Received |
|
|||
| P-064 | The Influence Of The Extent Of Lymph Node On The Prognosis For Patients With Intrahepatic Cholangiocarcinoma Undergone Surgery | Ying Zhang | Received |
|
|||
| P-065 | The Association Between Socioeconomic Status And Hepatocellular Carcinoma Mortality In The United States | Neehar Parikh | Received |
|
|||
| P-066 | Overall Survival Is Impacted By Liver Failure And Co-Morbidities Rather Than Etiology Of Cirrhosis In Patients With Hepatocellular Carcinoma Detected During A Surveillance Program | Nathalie Ganne-Carrié | Received |
|
|||
| P-067 | Role Of Alpha Fetoprotien Score And Aurora B Kinase In Prediction Of Hepatocellular Carcinoma Recurrence After Microwave Ablation. | Hend Naguib | Received |
|
|||
| P-068 | Recurrence Risk Reassessment (R3) Model Based On Explant Features Improves Prediction Of Hcc Recurrence Compared With Existing Models | Charlotte Costentin | Received |
|
|||
| P-069 | The Performance Of Non-Invasive Serum Tests In Predicting Clinically Significant Portal Hypertension And Posthepatectomy Liver Failure In Patients With CirrhosisComplicated With Hepatocellular Carcinoma | Iuliana Nenu | Received |
|
|||
| P-072 | Silencing Of Hepatic Discoidin Domain Receptor 1 Reduces Murine Liver Metastasis By Colon Carcinoma. Role Of Sinusoidal Discoidin Domain Receptor 1 In Liver Metastasis. | Irene Romayor | Received |
|
|||
| P-074 | Animal Models Of Liquid Biopsy In Hepatocellular Carcinoma Reveal Clone-Dependent Release Of Circulating Tumor Dna | Ismail Labgaa | Received |
|
|||
| P-076 | Immune-remodeling effects of lenvatinib plus anti-PD1 in a murine model of hepatocellular carcinoma | Laura Torrens | Received |
|
|||
| P-077 | Identification Of Neoantigen-Reactive Tumor-Infiltrating T Cell In Hepatocellular Carcinoma. | Enric Vercher Herraez | Received |
|
|||
| P-078 | Novel Strategies To Target Mitochondria In Bile Duct Cancers | Pietro Carotenuto | Received |
|
|||
| P-079 | Defining The Temporal Evolution Of The Gut Microbiome And Associated Intrahepatic Immune Response In The Mdr2-/- Model Of Hepatocellular Carcinoma | Jason Behary | Received |
|
|||
| P-080 | Cyclooxygenase 2 (Cox-2) Inhibition Counteracts Icam-1 Modulation Of Liver Microenvironment During Metastatic Development | Alba Herrero | Received |
|
|||
| P-081 | Cold-Inducible Rna Binding Protein As A Vaccination Platform Against Hepatocellular Carcinoma | David Repáraz | Received |
|
|||
| P-082 | Identification Of Neoantigens As Potential Vaccines In Hepatocellular Carcinoma. | David Repáraz | Received |
|
|||
| P-083 | Silencing Of Ddr1 Expression In Murine C26 Colon Carcinoma Reduces Experimental Liver Metastasis. Blockage Of Ddr1 Phosphorylation In Sinusoidal Cells Diminish Prometastatic Features Of C26 Cells. | Irene Romayor | Received |
|
|||
| P-084 | Trem2 Defends The Liver Against Hepatocellular Carcinoma Through Multifactorial Protective Mechanisms | Ibone Labiano | Received |
|
|||
| P-085 | Modeling Hepatocellular Carcinoma In The Minipig | Barbara Tschida | Received |
|
|||
| P-086 | Activated Peripheral Blood Lymphocytes Of Hepatocellular Carcinoma Patients (Hcc) Are Associated With Increased Risk Of Early Dermatologic Adverse Effects During Sorafenib Treatment | Josep Corominas Argente del Castillo | Received |
|
|||
| P-088 | Testis-Associated Lncrnas As Therapeutic Targets Against Hepatocellular Carcinoma | Juan Pablo Unfried | Received |
|
|||
| P-089 | Rsk2 Mutation-Driven Mapk Activation Sensitizes Sorafenib Treatment And DrivesCholesterol Metabolism In Hepatocellular Carcinoma | Irene Ng | Received |
|
|||
| P-090 | Implications of NOTCH3 Expression and Signaling for Cholangiocarcinogenesis | Sarah Fritzsche | Received |
|
|||
| P-091 | Dual Targeting Of Tumor Associated Macrophages And Immunosuppressive Granulocytic Myeloid-Derived Suppressor Cells Augments Pd-1 Blockade In Cholangiocarcinoma | Emilien Loeuillard | Received |
|
|||
| P-092 | Characterization Of Chromatin Accessibility In Hepatocellular Carcinoma Cells Using Single Cell Atac Sequencing | Amanda Craig | Received |
|
|||
| P-094 | Expression Of P62/Sqstm1 In Hepatocellular Carcinoma And Its Relation To Tumor Recurrence After Radiofrequency Thermal Ablation | Assem El-Shendidi | Received |
|
|||
| P-095 | Rac1 Inhibition As A New Therapeutic Target For Hcc | Juan Bayo | Received |
|
|||
| P-098 | Hepatic Arterial Infusion Chemotherapy For Post-Transplant Recurrent Hepatocellular Carcinoma After Failure Of Tyrosine Kinase Inhibitors | Jinfa Lai | Received |
|
|||
| P-103 | Exposure-response analysis for nivolumab ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040) | Onaisa Rizki | Received |
|
|||
| P-105 | Postprogression Survival After Lenvatinib Treatment For Advanced Hepatocellular Carcinoma | Yoshiyuki Wada | Received |
|
|||
| P-107 | Effect Of Pembrolizumab (Pembro) On Hepatitis B Virus (Hbv) Load And Aminotransferase (Alt) Levels In Patients (Pts) With Advanced Hepatocellular Carcinoma (Ahcc) In Keynote-224 And Keynote-240 | Philippe Merle | Received |
|
|||
| P-108 | Efficacy And Safety Of Lenvatinib As A Salvage Therapy Of Transarterial Treatment For Unresectable Hepatocellular Carcinoma | Jaejun Lee | Received |
|
|||
| P-109 | Post-Registration Experience Of Nivolumab Therapy In Patients With Advanced Hepatocellular Carcinoma (Hcc): An International Study. | Petros Fessas | Received |
|
|||
| P-113 | Surgical Outcomes Of Hepatocellular Carcinoma Within Milan Criteria In Our Department: Especially Assess By The Timing Of Sustained Virological Response | Yuko Takami | Received |
|
|||
| P-114 | Effects Of Molecular Target Agent Therapy In Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study | Kazufumi Kobayashi | Received |
|
|||
| P-115 | Sequential Treatment With Sorafenib Followed By Regorafenib In Patients With Unresectable Hepatocellular Carcinoma (HCC): Interim Analysis Of The Observational REFINE Study | Kathrina Quinn | Received |
|
|||
| P-121 | Hepatic Immune-Related Adverse Events During Immunotherapy: A Comparison Between Hcc And Liver Metastases From Other Solid Tumors | Antonio DAlessio | Received |
|
|||
| P-122 | Tumor Burden Score: A Useful Tool To Predict Immune-Related Hepatotoxicity During Immunotherapy For Hepatocellular Carcinoma | Antonio DAlessio | Received |
|
|||
| P-123 | Immunotherapy And Immune-Related Hepatitis In Hepatocellular Carcinoma: Outcomes And Tissue Biomarker Analysis | Nicola Personeni | Received |
|
|||
| P-126 | Nuclear Protein 1 (Nupr1) Expression Contributes To Sorafenib Resistance In Hepatocellular Carcinoma Cells Through Protective Autophagy Activation And P73 Inhibition | Melchiorre Cervello | Received |
|
|||
| P-127 | Real-Life Experience Of Regorafenib In Patients With Advanced Hepatocellular Carcinoma In China | Jingyu Hou | Received |
|
|||
| P-128 | Third-Line Chemotherapy In Advanced Biliary Cancers (Abc): Pattern Of Care, Treatment Outcome And Prognostic Factors From A Multicenter Study. | Massimiliano Salati | Received |
|
|||
| P-129 | Pilot Study Of Transarterial Radioembolization With Yttrium-90 In Patients With Hepatocellular Carcinoma | Pablo Florez-Diez | Received |
|
|||
| P-131 | The Efficacy And Safety Of Concurrent Chemoradiotherapy In Patients With Unresectable Hepatocellular Carcinoma | Hyun Woong Lee | Received |
|
|||
| P-133 | Tenofovir Vs Entecavir On Post-Operative Recurrence-Free And Overall Survival Of Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma | Jonggi Choi | Received |
|
|||
| P-135 | Survival And Morbidity Following Stereotactic Radiotherapy Of Hepatocellular Carcinoma: A 10 Year Single Institution Experience. | Hanna Rahbek Mortensen | Received |
|
|||
| P-136 | Transarterial Chemoembolization Versus Transarterial Radioembolization For Patients With Hepatocellular Carcinoma: A Meta-Analysis | Neehar Parikh | Received |
|
|||
| P-137 | Total Tumor Volume As A Prognostic Value For Survival Following Liver Resection In Patients With Hepatocellular Carcinoma. Retrospective Cohort Study | Mohamed Abdel-Samiee | Received |
|
|||
| P-138 | Treatment Sequencing Options In Advanced Hepatocellular Carcinoma: Preliminary Data From A Single-Centre Retrospective Cohort | Irene Pecora | Received |
|
|||
| P-139 | Selective Internal Radiation Therapy In Patients With Hepatocellular Carcinoma: A Retrospective Danish Study Of Efficacy | Gerda Elisabeth Villadsen | Received |
|
|||
| P-140 | Immune Profiling Of Combined hepatocellular-Cholangiocarcinoma | Julien Calderaro | Received |
|
|||
| P-200 | Prueba | Daniel Zaldumbide | Received |
|
|||
International Liver Cancer Association 14th Annual Conference
September 11-13, 2020 Virtual Conference
|
Poster submission deadline 24 August at 23:59 GMT+1
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 11/07/2020 TO 11/09/2021
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
|
|
